Journal of Mind and Medical Sciences
Volume 7

Issue 2

Article 4

2020

Diagnosis and management of pericardial effusion
Maria Manea
UNIVERSITY EMERGENCY CENTRAL MILITARY HOSPITAL, CARDIOLOGY CLINIC, BUCHAREST, ROMANIA

Ovidiu Gabriel Bratu
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF UROLOGY, UNIVERSITY
EMERGENCY CENTRAL MILITARY HOSPITAL, ACADEMY OF ROMANIAN SCIENTISTS, BUCHAREST,
ROMANIA

Nicolae Bacalbasa
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF VISCERAL SURGERY,
FUNDENI CLINICAL INSTITUTE, BUCHAREST, ROMANIA

Camelia Cristina Diaconu
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF INTERNAL MEDICINE,
CLINICAL EMERGENCY HOSPITAL OF BUCHAREST, BUCHAREST, ROMANIA

Follow this and additional works at: https://scholar.valpo.edu/jmms
Part of the Cardiology Commons, and the Critical Care Commons

Recommended Citation
Manea, Maria; Bratu, Ovidiu Gabriel; Bacalbasa, Nicolae; and Diaconu, Camelia Cristina (2020) "Diagnosis
and management of pericardial effusion," Journal of Mind and Medical Sciences: Vol. 7 : Iss. 2 , Article 4.
DOI: 10.22543/7674.72.P148155
Available at: https://scholar.valpo.edu/jmms/vol7/iss2/4

This Review Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion
in Journal of Mind and Medical Sciences by an authorized administrator of ValpoScholar. For more information,
please contact a ValpoScholar staff member at scholar@valpo.edu.

Journal of Mind and Medical Sciences

https://scholar.valpo.edu/jmms/
https://proscholar.org/jmms/
ISSN: 2392-7674

Diagnosis and management of pericardial effusion
Maria Manea1, Ovidiu Gabriel Bratu 2, Nicolae Bacalbasa 3, Camelia Cristina Diaconu 4
1

UNIVERSITY EMERGENCY C ENTRAL MILITARY H OSPITAL, C ARDIOLOGY C LINIC, BUCHAREST, ROMANIA

2

C AROL D AVILA UNIVERSITY OF M EDICINE AND PHARMACY, D EPARTMENT OF U ROLOGY, U NIVERSITY EMERGENCY C ENTRAL M ILITARY H OSPITAL, ACADEMY OF ROMANIAN SCIENTISTS,
BUCHAREST, ROMANIA
3
C AROL D AVILA UNIVERSITY OF M EDICINE AND PHARMACY, D EPARTMENT OF VISCERAL SURGERY, FUNDENI C LINICAL INSTITUTE, BUCHAREST, ROMANIA
4

C AROL D AVILA UNIVERSITY OF M EDICINE AND PHARMACY, D EPARTMENT OF I NTERNAL M EDICINE, C LINICAL EMERGENCY H OSPITAL OF BUCHAREST, BUCHAREST, ROMANIA

ABST RACT
Pericardial effusion is a common pathology in clinical practice. The etiology
of pericardial effusion is diverse, from infectious diseases, malignancies,
autoimmune diseases, chronic renal failure, to drug-related or after an
invasive cardiac intervention. Clinical presentation of pericardial effusion is
variable, depending on the volume of the fluid and the rate of accumulation.
Clinical manifestations are dramatic if the pericardial fluid accumulates
rapidly. Classical symptoms in pericardial effusion include pleuritic chest
pain associated with dyspnea. In case of cardiac tamponade, orthopnea,
jugular venous distension, pulsus paradoxus, hypotension, and shock appear.
Transthoracic echocardiography is the gold standard investigation for the
diagnosis of pericardial effusions. The echocardiographic signs of cardiac
tamponade are represented by the collapse of the right atrium and right
ventricle, respiratory alteration of mitral and tricuspid flow, and changes of
the inferior vena cava. Management of pericardial effusion is guided by
several factors, including hemodynamic impact and etiology.
Pericardiocentesis guided by echocardiography is a life-saving procedure in
cases of large pericardial effusions and cardiac tamponade. This is a review
of the diagnosis and treatment of pericardial effusion.

Introduction
The pericardium is a double-layered membrane that
covers the heart. It consists of a fibrous and a serous layer
and encloses the pericardial cavity, which contains,
physiologically, 15-50 mL of pericardial fluid. The
pericardium provides mechanical protection of the heart
and against infections.
Pericarditis is a common pathology, caused by
inflammation of the pericardium. Usually, pericarditis is
associated with pericardial effusion, by accumulation of
pericardial fluid that can be serous, hemorrhagic, or
purulent, depending on the etiology. Snyder et al observed
that acute pericarditis is reported in 5% of patients
presented to the emergency room for chest pain [1].
Cardiac tamponade is a critical condition, that occurs after
rapid or excessive accumulation of pericardial fluid,
associated with hemodynamic instability.
The prevalence of pericarditis can be difficult to
estimate because in some cases the accumulation of
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pericardial fluid can be clinically insignificant. The
incidence of pericardial diseases is estimated to be 2 cases
per 10 000 persons [2].
Pericardial effusion is classified by its onset as acute,
subacute, or chronic and by its distribution in
circumferential or loculated. Pericardial effusion is
classified also based on hemodynamic impact (with or
without cardiac tamponade) or by its composition (exudate,
transudate,
hemopericardium,
pyo-pericardium).
Depending on the effusion volume, pericardial effusion can
be mild, moderate, or large [1].

Discussions
Etiology of pericardial effusion
The etiology of pericardial effusion is varied (Table 1).
The 2015 European Society of Cardiology Guideline for
the management of pericardial effusion classified the
etiology into infectious and non-infectious [3]. Among
infectious causes, the most common agents are viruses,
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such as Coxsackie A and B, echovirus, adenovirus,
influenza, and human herpes virus. Bacterial infections that
can lead to pericardial effusion are represented by Coxiella
burnetii, meningococcus, pneumococcus, staphylococcus
and streptococcus [4].

A review by Mayosi et al in 2005 reported that
tuberculosis is the most common cause of pericarditis in
developing countries [5]. Another review reported that the
incidence of tuberculous pericarditis is increasing in
Africa, as a result of the HIV epidemic [6].

Table 1. The etiology of pericardial effusion [3,7].
1.1. Infectious causes of pericardial effusion
Viral

Enteroviruses (Coxsackie viruses, Echoviruses), Herpes viruses, Epstein-Barr virus,
cytomegalovirus, adenoviruses, parvovirus B19

Bacterial

Mycobacterium tuberculosis, Coxiella, Borrelia, pneumococcus, meningococcus, gonococcus,
streptococcus, Chlamydia, Mycoplasma, Legionella

Fungal

Histoplasma, Aspergillus, Candida

Parasitic

Echinococcus, Toxoplasma
1.2. Non-infectious causes of pericardial effusion

Autoimmune

Systemic autoimmune and auto-inflammatory diseases (systemic lupus erythematosus, Sjogren
syndrome, rheumatoid arthritis, systemic vasculitides, sarcoidosis, inflammatory bowel diseases

Neoplastic

primary tumors (pericardial mesothelioma), secondary metastatic tumors (lung and breast
cancer, lymphoma)

Metabolic

uremia, myxedema

Traumatic and
iatrogenic

direct or indirect thoracic injury, postmyocardial infarction syndrome, post-pericardiotomy
syndrome, after iatrogenic cardiac procedures

Other

amyloidosis, aortic dissection, pulmonary arterial hypertension, chronic heart failure, partial or
complete congenital absence of the pericardium

Drug-related

procainamide, hydralazine, methyldopa, doxorubicin, 5-fluorouracil, amiodarone, mesalazine,
bromocriptine

Pericardial effusion can be secondary to noninfectious
diseases, such as autoimmune diseases (systemic lupus
erythematosus, rheumatoid arthritis, Sjogren syndrome,
sarcoidosis), primary tumors (pericardial mesothelioma) or
secondary tumors (most common lung cancer and breast
cancer, lymphomas and melanoma), acute myocardial
infarction (Dressler syndrome), chronic renal failure [8],
hypothyroidism (myxedema), mediastinal radiation, direct
injury (penetrating thoracic injury), drugs (especially
procainamide, hydralazine), and after an invasive cardiac
procedure (post-pericardiotomy syndrome), or it may have
hemodynamic causes (heart failure, pulmonary
hypertension) [3]. In a study that enrolled 114 patients with
neoplasia, pericardial diseases were diagnosed in 18% of
cases throughout the monitoring period [9].
In many cases, the etiology of pericarditis is difficult to
establish. Multiple studies on this issue have revealed that
the cause of pericarditis is idiopathic in 90% of cases [4].
Cardiac tamponade can be caused by chest trauma

complicated
with
pericardial
hemorrhage
(hemopericardium), ventricular wall rupture after acute
myocardial infarction, or after invasive cardiac procedures
[3].
Pathophysiology of pericardial effusion
The pericardium has the role to provide mechanical
protection to the heart, to act as a barrier against infections,
and to ensure dynamic interactions of the heart chambers.
The normal pericardium contains 10-50 mL of pericardial
fluid, which is an ultrafiltrate of plasma. The interactions
of the pericardium with pleural lymphatics and the
lymphatic drainage of the pericardial fluid to the
mediastinal and tracheobronchial lymph nodes explain the
pathological involvement of the pericardium in pulmonary
diseases [9].
Depending on the mechanism of appearance, the
pericardial effusion can be classified into exudate and
transudate. Pericardial fluid is an exudate when it is the
result of an inflammatory pericardial process, which
149
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determines an increased production of pericardial fluid.
The transudate appears when the reabsorption of the
pericardial fluid decreases due to the increased systemic
venous pressure; thus, the fluid accumulates in the
pericardium, as in heart failure or pulmonary hypertension
[4].
The normal pericardium has a J-shaped pressurevolume curve. A slow accumulation of 1-2 L of pericardial
fluid, over several weeks or months, will lead to a modest
increase in pericardial pressure, without cardiac tamponade
until advanced stages [10]. Usually, pericardial effusions
caused by infections, autoimmune diseases, or
malignancies are associated with a slow accumulation of
the fluid. In these cases, the compliance of the pericardium
increases, and the pericardial sac dilates without
compression of the heart [4].
A sudden increase in the pericardial fluid is associated
with increased intrapericardial pressure. Intrapericardial
pressure increases rapidly to 20-30 mmHg or more at a
sudden increase of 100-200 mL of pericardial fluid (in
cases of hemopericardium) and this can lead to cardiac
tamponade [11]. Cardiac tamponade results from the rapid
accumulation of the pericardial fluid. In the development
of cardiac tamponade, some factors influence the
hemodynamic consequences. These factors are represented
by the rapidity of fluid accumulation, subjacent cardiac
disease and the pericardial pressure-volume relationship.
The ongoing accumulation of pericardial fluid increases
the intrapericardial pressure. The compensatory
mechanisms are the increased central systemic pressure
and pulmonary venous pressure, for equalizing the
pericardial pressure and preventing the collapse of the
heart. Stroke volume is reduced, but in the first stages, the
cardiac output is maintained. Also, the increased
ventricular pressure leads to pulmonary hypertension to
maintain pulmonary circulation. In these cases, pulmonary
arterial pressure increases to 40 mmHg [12,13].
As the pericardial fluid continues to accumulate, the
pericardium becomes inextensible. A discordance in filling
and ejection between the left and the right ventricle will
appear. This is called ventricular interdependence,
meaning that any changes that appear in the volume of one
side of the heart determine the opposite changes in the
volume of the other side. The clinical manifestation that
appears in this context is represented by pulsus paradoxus.
The dilatation of the right ventricle leads to the bowing of
the interventricular septum into the left ventricle, with a
reduced left ventricle preload. When the pericardial
pressure is above 25 mmHg, the cardiac output is
decreased and the blood pressure is reduced, resulting in
cardiogenic shock and circulatory collapse [14]. The
pericardial drainage and removal of 100 mL of fluid may
reduce the pericardial pressure, which is lifesaving in
cardiac tamponade [15].
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Clinical presentation and paraclinical tests
Clinical presentation of pericardial effusion is variable,
depending on the volume of fluid and rate of accumulation.
Clinical manifestations are dramatic if the pericardial fluid
accumulates rapidly. Classical symptoms in pericardial
effusion include pleuritic chest pain, relieved when the
patient leans forward, associated with dyspnea at exertion
that can progress to orthopnea. Other symptoms may
appear due to local compression, such as nausea and
dysphagia. Depending on the etiology of pericardial fluid,
nonspecific symptoms may appear, such as cough,
weakness, palpitations, or fatigue [3].
Cardiac auscultation reveals diminished heart sounds.
Pulmonary auscultation identifies sometimes a left
parasternal pericardial friction rub. This is a sound
corresponding to friction between the pericardium layers.
In the literature, the friction rub is reported in 35-85% of
the cases of pericarditis [16]. Physical examination in
cardiac tamponade reveals jugular venous distension,
tachypnea, tachycardia, pulsus paradoxus, hypotension,
and cold extremities. Pulsus paradoxus means a decrease
in systolic blood pressure by more than 10 mmHg with
inspiration [6]. Pulsus paradoxus appears in cardiac
tamponade due to ventricular interdependence, when the
volume of the cardiac chambers is fixed. The classical
finding at the physical examination in patients with cardiac
tamponade is Beck’s triad, which includes arterial
hypotension, jugular venous distension, and muffled heart
sounds [17]. Data from the literature reveal that signs of
Beck’s triad are identified especially in cases of cardiac
tamponade due to hemopericardium, as a result of thoracic
injury or acute rupture of the ventricular wall [4].
Laboratory tests may show leukocytosis and high levels
of inflammatory markers in pericardial effusion caused by
infectious and inflammatory diseases. Also, in these cases,
liver and renal function must be evaluated, together with
thyroid stimulating hormone, and different markers in case
of suspected viral infection. In cases of high suspicion of
tuberculosis, tests such as PPD or quantiferon TB will be
performed [10].
The electrocardiogram (ECG) performed in patients
with pericarditis shows changes that evolve through stages
[11]. In stage I, the ECG presents a diffuse elevation of the
ST-segment. In stage II, the ST segment normalizes. Stage
III and stage IV are characterized by T wave inversions,
followed by T wave normalization. ECG changes appear in
more than half of the patients [18]. In cardiac tamponade,
the ECG reveals sinus tachycardia and low-voltage
complexes. Electrical alternation on ECG is characteristic
in cases of large pericardial effusion.
The European Society of Cardiology guideline for
pericardial diseases requires two out of the following four
criteria for the diagnosis of acute pericarditis: pericardial
chest pain, pericardial rub, ST-segment elevation on ECG
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and pericardial effusion [3]. In cases of tuberculous
pericardial effusion, the diagnosis is made when there are
a lymphocytic pericardial exudate and elevated ADA
levels [6].
Transthoracic echocardiography is the gold standard
method for the diagnosis of pericardial effusions. M-mode
and two-dimensional Doppler ecocardiography should be
performed to evaluate the pericardial fluid, its distribution,
size, and hemodynamic effects [16]. On two-dimensional
echocardiography, pericardial effusion appears as an echofree space. In this case, the clinician should assess the
location of the fluid and the hemodynamic impact. Small
pericardial effusions are localized over the postero-basal
left ventricle. Then, as the pericardial fluid increases, it will
be visible anterior or lateral. Any pericardial effusion from
5 to 10 mm in diastole is considered small, 10 to 20 mm is
moderate, and greater than 20 mm is considered large.
Swinging heart is a sign of large effusion at
echocardiography [10].
In cardiac tamponade, echocardiography will show the
diastolic collapse of the right heart cavities, the most
characteristic ultrasonographic sign [19]. Usually, the
compression of the right atrium for more than one-third of
the cardiac cycle is specific for cardiac tamponade [20].
The collapse of the left atrium appears in 25% of the cases
of tamponade [21]. Also, Doppler echocardiography is
used to estimate respiratory variations in the mitral and
tricuspid flow –a decrease in the peak mitral inflow
velocity with >30% and an inspiratory increase of the peak
of tricuspid inflow velocity with >50% suggest an
increased ventricular interdependence [22]. The inferior
vena cava is dilated in these cases and shows a less than
50% reduction of its diameter during inspiration, as a sign
of an increased central venous pressure [23]. The
echocardiographic changes of the inferior vena cava
associated with pulsus paradoxus at the physical
examination are present in 92% of cases of cardiac
tamponade [24]. Also, echocardiography will show
abnormal septal motion in the case of cardiac tamponade.
The clinician should correlate the echocardiographic
signs of cardiac tamponade, such as collapse of the right
atrium and right ventricle, respiratory alteration of mitral
and tricuspid flow, and changes of the inferior vena cava,
with the clinical signs of tamponade – dyspnea,
tachycardia, jugular venous distension, pulsus paradoxus,
hypotension, and shock [25].
Other imaging tests, such as computed tomography
(CT) scan or magnetic resonance imaging (MRI) can
describe the characteristics of the pericardial effusion and
cardiac tamponade. The cardiac CT scan may reveal
pericardial fluid accumulation, but this method cannot be
used to assess hemodynamic parameters. The cardiac MRI

evaluates the pericardium morphology but requires more
time and has higher costs [26].
The biochemical analysis of the pericardial fluid is
recommended to assess the etiology of the pericardial
effusion [3]. These tests can determine whether the
etiology of the pericardial fluid is infectious or neoplastic.
The pericardial fluid required for these tests will be
obtained by pericardial drainage, and cultures for aerobes
and anaerobes will be performed, together with other tests,
depending on the suspected etiology. Also, the biochemical
analysis of the pericardial fluid can distinguish the exudate
from transudate [27].
Differential diagnosis of pericardial effusion
There are several diseases with similar symptoms that
should be considered in the differential diagnosis of
pericardial effusion, such as pulmonary embolism,
congestive heart failure, acute coronary syndrome, and
cardiogenic pulmonary edema. In these cases, the
differential diagnosis is based on the chest pain
characteristics, laboratory tests (cardiac enzymes, Ddimers, NT-proBNP), and imaging investigations
(echocardiography, CT scan). Other causes of chest pain
that should be considered in these patients are represented
by gastritis, esophagitis, or peptic ulcer disease [11]. Also,
the differential diagnosis of cardiac tamponade includes
other causes of cardiogenic shock, such as pulmonary
embolism or type A aortic dissection with extension into
the pericardium [2].
Treatment of pericardial effusion
Medical treatment
Medical treatment in patients diagnosed with
pericardial effusion whose tests show elevated
inflammatory markers and develop inflammatory signs and
symptoms, such as fever, is represented by high dose of
non-steroidal anti-inflammatory drugs (NSAIDs) or
aspirin, associated with colchicine [3] (Table 2). Several
studies showed good results when colchicine is associated
with aspirin or NSAIDs in the treatment of pericarditis
[28]. Idiopathic and viral pericarditis associated with
pericardial effusion is often responsive to this combination
of drugs [29,30]. The treatment will be targeted for the
causative agent in cases where the specific etiology is
known (viral or bacterial infections). Low or moderate
doses of corticosteroids are not recommended as first-line
treatment, because this class is associated with the risk of
recurrent pericarditis. Corticosteroids are administered
usually when there are specific indications or in cases of
intolerance to aspirin or NSAIDs [28]. The therapeutic
response is evaluated based on the relief of the symptoms,
associated with an improvement of the biological
parameters.
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Table 2. Drug treatment options for pericardial effusion [3].
Drug

Usual dose

Duration

Lowering doses

Aspirin

750-1000 mg every 8h

1-2 weeks

Decrease doses by 250-500 mg every 1-2 weeks

Ibuprofen

600 mg every 8h

1-2 weeks

Decrease doses by 200-400 mg every 1-2 weeks

Colchicine

0.5 mg b.i.d (>70 kg) or
0.5 mg once (<70 kg)

3 months

Not mandatory

Corticosteroid

0.2-0.5 mg/kg/day of
Prednisone

When a complete response is obtained, lowering doses
should be considered, initially with a single class of drugs
at a time. Each tapering is done if the patient is
asymptomatic and the values of inflammatory markers are
normal [3].
Pericardial effusion developed after acute myocardial
infarction complicated with rupture of the ventricle wall
may result in hemopericardium. Studies show that up to
two-thirds of these patients may present cardiac tamponade
in the context of ventricular free wall rupture. In these
cases, urgent treatment is life-saving [31].
Purulent pericardial effusion is associated with high
mortality, so these patients should be treated aggressively.
In the context of a tuberculous etiology of pericardial
effusion, the treatment includes anti-tuberculosis drugs
administered for at least 6 months. In these cases, the
clinician should consider pericardiectomy if there is a
failure of clinical improvement with medical therapy [32].
If the medical treatment is not effective in case of
symptomatic pericardial effusion with no inflammatory
signs, the clinician may consider pericardial drainage.
Pericardial drainage
Pericardial drainage can be performed by
pericardiocentesis or by an open surgical method.
Percutaneous needle pericardiocentesis is a procedure used
for diagnosis or therapeutic purposes. In cases of
symptomatic large pericardial effusion or cardiac
tamponade, pericardiocentesis is the most useful
therapeutic procedure. This is a life-saving method,
indicated when echocardiography shows diastolic
pericardial effusion >20 mm associated with hemodynamic
impact [18].
Also, pericardiocentesis is performed in patients with
chronic idiopathic pericardial effusion who remain
asymptomatic, but who can develop unexpected
tamponade. In a study performed by Sagrista et al, who
followed patients diagnosed with chronic idiopathic
pericardial effusion, cardiac tamponade appeared in 29%
of cases during the course of the disease [7]. Numerous
studies on this issue have confirmed that complications are
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− at 50 mg/day: tapering with 10 mg/day every
1-2 weeks
− 25-50 mg: 5-10 mg/day every 1-2 weeks
− 15-25mg: 2.5 mg/day every 2-4 weeks
reduced with 20% when percutaneous pericardiocentesis is
guided by transthoracic echocardiography [33]. The
feasibility of pericardiocentesis is 90% in cases when the
pericardial fluid is localized anterior to the ventricle and
<60% in cases of posterior localization [34].
Pericardiocentesis involves the removal of pericardial fluid
by percutaneous catheterization of the pericardium, being
an urgent procedure in cases of acute tamponade [18].
There are three approaches for pericardiocentesis – left
parasternal, sub-xyphoid and left apical. Usually, the subxyphoid approach is used to avoid injury of the major
arteries [33].
Halpern et al suggested a pericardial effusion scoring
index, which consists of 3 components: the etiology of
pericardial effusion, the size of the effusion, and
echocardiographic signs. According to this index,
pericardiocentesis could be performed when the score is 4
or higher [35]. Hyun et al conducted a study in 2007 on 116
patients diagnosed with symptomatic pericardial effusions,
who were treated by pericardiocentesis guided by
echocardiography. Common causes of pericardial effusion
in these patients were lung cancer in 27% of cases,
tuberculosis in 13.8%, and uremia in 6.9% of patients.
Pericardiocentesis performed in these cases had a rate of
success of 99.1% [18].
Malignant pericardial effusion can be a complication of
lung or breast cancer or lymphomas. In these cases,
pericardial
drainage
can
be
performed
by
pericardiocentesis or by surgical drainage, depending on
the patient’s prognosis and risks. Many patients with a
malignant pericardial effusion have a poor prognosis; in
this context, the purpose of the treatment is to improve the
quality of life [20].
Tsang et al confirmed that echocardiography can
rapidly confirm the presence of pericardial effusion after
cardiothoracic surgery. In these cases, pericardiocentesis
performed under echocardiographic guidance is safe and
efficient. Also, it was confirmed that the use of a
pericardial catheter for drainage is associated with lower
recurrence rates [36]. Lindenberger et al conducted a
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retrospective study, which included 252 patients with
pericardial effusion. This study confirmed that
pericardiocentesis guided by echocardiography is a safe
and efficient method for patients with malignant etiology
of the pericardial effusion [37].
Retrospective studies and case reports indicate
pericardiocentesis with prolonged drainage (<30 mL/24h)
to prevent re-accumulation of the fluid [35]. In cases when
pericardiocentesis fails or is not feasible, the clinician
should consider performing a pericardial window [24].
This technique uses sub-xyphoid approach under
echocardiographic guidance and involves the insertion of a
catheter into the pericardial space. This technique is
efficient in preventing recurrence in >80% of cases [38].
The
most
important
complications
of
pericardiocentesis are represented by perforation of the
myocardium, injury of the coronary arteries,
pneumothorax, air embolism, or puncture of the peritoneal
cavity [34]. These complications are reduced by using the
echocardiographic guidance. In a large review on this
issue, the incidence of complications in echocardiographyguided
pericardiocentesis
was
1-1.6%
[38].
Pericardiocentesis is contraindicated in aortic dissection.
Surgical drainage is a method used when pericardial
drainage performed by pericardiocentesis is not feasible or
has failed. This method is used in cases of
hemopericardium, purulent pericarditis, recurrent
malignant effusion, or when the pericardial effusion is
localized posterior [39]. Surgical drainage can be
performed by different techniques: complete or partial
pericardectomy, subxyphoid pericardiotomy, anterior
transthoracic window, all methods having the same
efficiency [40].
In cases of idiopathic moderate pericardial effusions, an
echocardiographic follow-up will be necessary every 6
months. Patients with severe pericardial effusion require an
echocardiographic reassessment every 3-6 months after
discharge [41].
Evolution and prognosis
The prognosis for patients with pericardial effusion
depends on etiology. Patients with a neoplastic pericardial
effusion have a poor prognosis. The evolution is favorable
in patients with viral or idiopathic pericardial effusion.
Also, the size of the effusion is correlated with prognosis.
A mild idiopathic effusion is associated with a good
prognosis and does not need special monitoring, the
patients being mostly asymptomatic. Large pericardial
effusions are associated with a high risk of progression to
cardiac tamponade. Moderate to large pericardial effusions
may evolve to cardiac tamponade in up to one-third of
cases [3].

Recurrent pericardial effusion can occur in 30% of cases
when patients are not treated with colchicine [3]. Another
complication is constrictive pericarditis, which occurs in
<1% of cases [5]. The most feared complication in patients
with pericardial effusion is represented by cardiac
tamponade. This complication rarely occurs in cases of
idiopathic pericardial effusion but is more common in
neoplastic forms [4].

Highlights
✓ The etiology of pericardial effusion is diverse, from
infectious diseases, malignancies, autoimmune
diseases, chronic renal failure, to drug-related or after
an invasive cardiac intervention.
✓ Classical symptoms in pericardial effusion include
pleuritic chest pain, associated with dyspnea.
✓ Transthoracic echocardiography is the gold standard
investigation for the diagnosis of pericardial effusions.
The echocardiographic signs of cardiac tamponade are
represented by the collapse of the right atrium and
right ventricle, respiratory alteration of mitral and
tricuspid flow, and changes of the inferior vena cava.
✓ Pericardiocentesis guided by echocardiography is a
life-saving procedure in cases of large pericardial
effusions and cardiac tamponade.

Conclusions
Pericardial effusion may have different etiologies, such
as infectious diseases, malignancies, chronic renal failure,
thyroid disease, or autoimmune diseases, after cardiac
interventions, or it can be idiopathic. Transthoracic
echocardiography is the most useful investigation for the
diagnosis of pericardial effusion. Large pericardial
effusions require pericardial drainage performed by
percutaneous pericardiocentesis or by surgical procedure.
Pericardiocentesis guided by echocardiography is a lifesaving procedure in cases of large pericardial effusions and
cardiac tamponade.
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